Skip to main content

Table 3 Main pros and cons of the two main valuation methodologies (Bogdan and Villiger 2010)

From: Valuations using royalty data in the life sciences area—focused on anticancer and cardiovascular therapies

 

Advantages

Disadvantages

DCF

Easy to implement and to understand

Misses the value of flexibility and market uncertainty

Standard in all sectors of the economy

Not suitable for risk management

Real Options

Captures market uncertainty and the management’s ability to react

Relies on more hypothesis and requires more data

Suitable for risk management

Technical

Improves strategic thinking if properly understood